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Abstract 
Objective: The strongest risk factor for depression during pregnancy is a history of depression, 
and depression and anxiety during pregnancy can lead to adverse maternal, birth, and early 
childhood outcomes.  There is a research gap in multigenerational studies that examine the 
influence of heredity on the development of maternal mood disorders during pregnancy and the 
postpartum period.  The purpose of our research was to determine if a history of major 
depressive disorder (MDD) and/or anxiety in the pregnant woman’s mother (maternal 
grandmother, or MGM) predicts the same psychiatric illness in the pregnant woman and if a 
family history of depression and/or anxiety correlates with maternal and fetal hypothalamic-
pituitary-adrenocortical (HPA) axis function, as represented by hair cortisol.  We also sought to 
determine if a family history of psychiatric illness correlates with maternal and fetal hair cortisol 
concentration and maternal scores on the Center for Epidemiological Studies of Depression Scale 
(CES-D) and the State-Trait Anxiety Inventory (STAI). 
Methods: Pregnant participants ≥18 years old without major psychiatric or physical 
comorbidities were enrolled in a prospective longitudinal study at ≤15 weeks gestation.  Family 
history of psychiatric illness was abstracted from a Structured Clinical Interview for DSM-IV 
Disorders (SCID), conducted during a scheduled study visit.  Maternal diagnoses of MDD and 
anxiety were compared with the MGM’s psychiatric history.  CES-D and STAI scores for 
participants who had a MGM with depression and/or anxiety were compared with participants 
who had no family history of psychiatric illness. Maternal hair was collected at 16 and 28 weeks 
and maternal and fetal (neonatal) hair was collected following delivery for cortisol analysis.   
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Results: 153 participants in the study had data for analysis.  Of these, 40% met criteria for MDD 
and 24% for an anxiety disorder (including PTSD) as determined by SCID.  CES-D and STAI 
scores for participants with a history of MDD and/or anxiety in the MGM were higher compared 
to participants with no family history of psychiatric illness (p=0.02 and p=0.005), and these 
scores corresponded with the respective scales (CES-D for MDD and STAI for anxiety). A 
history of depression and/or anxiety in the MGM was not significantly correlated with maternal 
HPA axis function as represented by hair cortisol.   
Conclusion: History of MDD and/or anxiety in the MGM is associated with maternal scores on 
the CES-D and STAI that are consistent with depression and anxiety.  A history of depression 
and/or anxiety in the MGM also predicts the same psychiatric illness in the pregnant participant.  
Healthcare providers must consider family history of psychiatric illness to improve recognition, 
diagnosis, and treatment of depression and anxiety during prenatal and postpartum care.   
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Introduction and Literature Review 
Maternal stress during pregnancy can lead to adverse maternal, fetal, and 
neurodevelopmental childhood outcomes.  According to Kalra et al. (2007), stress is defined as 
“a state of bodily or mental tension resulting from factors that tend to alter an existent 
equilibrium,” and is clearly present in conditions of depression and anxiety.  Therefore, presence 
of maternal depression and/or anxiety during pregnancy is linked to negative impacts on 
maternal mental health, pregnancy outcomes, fetal development, and neurodevelopmental 
childhood outcomes (Bergman, Sarkar, Glover, & O’Connor, 2010; Dunkel Schetter & Tanner, 
2012; Glover, 2014; Kalra, Einarson, Karaskov, Van Uum, & Koren, 2007).  More specifically, 
maternal anxiety during pregnancy is linked with preterm delivery and maternal depression 
during pregnancy is linked with lower fetal birth weight, and both psychiatric illnesses are linked 
with learning, behavior, and motor development problems during childhood (Bergman et al., 
2010; Dunkel Schetter & Tanner, 2012; Field & Diego, 2008; Glover, 2014; Hoffman, Mazzoni, 
Wagner, Laudenslager, & Ross, 2016; O’Donnell, O’Connor, & Glover, 2009).  These adverse 
effects could be due to changes in functioning of the maternal hypothalamic-pituitary-
adrenocortical (HPA) axis and to consequent changes in development of the fetal nervous system. 
Defining MDD and Anxiety 
MDD is defined by many symptoms, often working in concert, that will interfere with an 
affected patient’s ability to work, sleep, eat, and experience activities that they once enjoyed 
(National Institute of Mental Health, 2007).  Anxiety disorders are characterized by both mental 
and physiological overreactions to what patients believe to be stressful (Staufenbiel, Penninx, 
Spijker, Elzinga, & van Rossum, 2013).  Patients who are diagnosed with MDD are often also 
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diagnosed with an anxiety disorder, such as generalized anxiety disorder (GAD), post-traumatic 
stress disorder (PTSD), obsessive-compulsive disorder (OCD), and certain phobias (National 
Institute of Mental Health, 2007).  PTSD is diagnosed as a specific anxiety disorder under the 
DSM-IV, but is a stand-alone psychiatric illness according to the recently released DSM-V.  For 
this study, PTSD is treated as an anxiety disorder with this recent change in mind, and is defined 
as an anxiety disorder that arises after a patient experiences a traumatic event; examples of which 
could be a car accident, abuse, or exposure to military combat (National Institute of Mental 
Health, 2007). 
The “Depression Gene” 
It is important to clarify that no studies have yet found a so-called “depression gene.”  It 
is possible that the genotype for a specific serotonin transporter (5-HTTLPR) could be associated 
with the heredity of depression.  Risch et al. (2009) performed a meta-analysis of literature on 
serotonin transporter 5-HTTLPR and concluded that while the number of stressful life events 
was significantly associated with depression, there is no association between the serotonin 
transporter 5-HTTLPR genotype and depression in any of the individual studies or in the 
weighted average of studies used for the meta-analysis.  Overall, the meta-analysis resulted in no 
evidence that the 5-HTTLPR genotype, whether analyzed alone or in conjunction with stressful 
life events, is associated with an elevated risk of depression in men alone, women alone, or in 
both sexes (Risch et al., 2009).   
Despite the lack of association in genetic studies, there is a consensus that mood 
disorders are hereditary in some way even though the biological mechanisms are not yet 
understood.  There does seem to be a hereditary influence on the development of certain 
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psychiatric illnesses, as Weissman et al. (2005, 2006) found that children of depressed parents 
were about three times as likely to develop MDD, anxiety disorders, and/or substance use 
disorders. 
HPA Axis Functioning in MDD and Anxiety 
 Both hyper- and hypo activity of the HPA axis are seen in populations of patients who are 
diagnosed with psychiatric illnesses such as MDD and anxiety, and this hyper or hypo activity 
may actually lead to the development of certain pathologies (S. M. Smith & Vale, 2006; 
Staufenbiel et al., 2013).  It is uncertain whether hyper or hypo activity of the HPA axis is seen 
in PTSD.  There is some consensus that there is dysregulation and hypoactivity of the HPA axis, 
but several studies conclude that more research much be done to study the HPA axis in those 
diagnosed with PTSD (de Kloet et al., 2006; Meewisse, Reitsma, Vries, Berthold, & Olff, 2007; 
Shea, Walsh, MacMillan, & Steiner, 2005). 
HPA Axis Functioning in Pregnancy 
Cortisol is a stress hormone that is regulated by the HPA axis.  When a stressor is 
introduced, the hypothalamus produces corticotropin-releasing hormone (CRH), which then 
triggers the pituitary to release adrenocorticotropic hormone (ACTH).  This stimulates the 
adrenal cortex to secrete cortisol, which is released in response to chronic stress (Osborne & 
Monk, 2013; Staufenbiel et al., 2013). 
Cortisol levels fluctuate greatly throughout the day and tend to be highest in the morning.  
Cortisol levels as measured in the morning are 6 to 23 micrograms per deciliter (mcg/dL) (U.S. 
National Library of Medicine, 2015).  This is a wide range because cortisol levels vary between 
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patients and between measurements; however, this is the standard cortisol range when cortisol 
measurements are taken in the morning. 
Due to hyperactivity of the HPA axis, pregnancy is a state of hypercortisolemia, with 
cortisol levels increasing during the third trimester of pregnancy especially (D’Anna-Hernandez, 
Ross, Natvig, & Laudenslager, 2011; Hoffman et al., 2016; Kalra et al., 2007).  Therefore, 
maternal cortisol levels increase during pregnancy, but significant increases in maternal cortisol, 
in particular during the second trimester of pregnancy, are linked with the aforementioned 
adverse maternal, fetal, and childhood neurodevelopmental effects (Hoffman et al., 2016; Kalra 
et al., 2007).  
Moreover, while cortisol is absolutely necessary during pregnancy to facilitate normal 
fetal development, elevated maternal cortisol levels tend to accompany pathological diagnoses (S. 
M. Smith & Vale, 2006; Wadhwa et al., 2004).  Diagnoses of depression and anxiety are one of 
the most common complications of pregnancy.  Anxious mothers have higher cortisol levels 
during both the prenatal and postpartum periods, and depressed mothers show either increased or 
decreased cortisol levels during the prenatal and postpartum periods, implying that more research 
regarding cortisol levels in participants with depression are needed (Staufenbiel et al., 2013).  
The hypercortisolemia seen in pregnancy suggests that different mechanisms regulate cortisol 
release during pregnancy and outside of pregnancy. 
Outside of pregnancy, glucocorticoids such as cortisol are the downstream effectors of 
the HPA axis.  They regulate physiological changes through intracellular receptors that respond 
to inadequate or excessive activation of the HPA axis via negative feedback (S. M. Smith & Vale, 
2006).  As soon as levels of circulating glucocorticoids increase past a threshold value, the same 
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circulating glucocorticoids inhibit HPA axis activation through the hypothalamus and the 
pituitary gland (S. M. Smith & Vale, 2006).  
There is a different mechanism at work in regards to the release of placental 
corticotropin-releasing hormone (pCRH) during pregnancy.  Cortisol follows a positive feedback 
mechanism during pregnancy and pCRH production is increased.  pCRH then stimulates the 
maternal HPA axis to increase ACTH secretion, which directly stimulates maternal cortisol 
secretion and therefore contributes to hypercortisolemia during pregnancy (Majzoub & Karalis, 
1999).  Since 10-20% of maternal cortisol crosses the placenta and enters the fetus, one possible 
mechanism could be that elevated maternal cortisol levels (as seen during pregnancy) can 
stimulate an increase in fetal cortisol through increasing the release of pCRH through 
hyperactivity of the HPA axis (Field & Diego, 2008).  This can influence timing of delivery, 
which helps explain the high preterm delivery rates of pregnant women who have depression 
and/or anxiety (Field & Diego, 2008). 
While hypercortisolemia during pregnancy is associated with adverse maternal, fetal, and 
neurodevelopmental childhood outcomes, ample glucocorticoid levels are actually vital for fetal 
development.  Glucocorticoids promote brain development by stimulating neurons to mature, 
remodeling synaptic connections, and pruning unnecessary synaptic connections (Glover, 2014; 
Harris & Seckl, 2011).  Sufficient glucocorticoid levels are essential for normal maturation of the 
central nervous system.   
Possible Cortisol Release Mechanisms During Pregnancy 
First trimester maternal cortisol levels represent the mother’s baseline cortisol status and 
maternal cortisol levels increase during the second and third trimesters of pregnancy.  A decrease 
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in cortisol binding globulin, the carrier protein for cortisol, and increases in pCRH during the last 
four to six weeks of pregnancy could explain why there is a cortisol increase during pregnancy 
(Kalra et al., 2007). 
Another mechanism for the cortisol increase seen in pregnancy could be due to an 
increase in the expression of the protein 11-beta-hydroxysteroid dehydrogenase type 2 (11β 
HSD2), which is an enzyme that shields the fetus from the mother’s glucocorticoid levels by 
converting the active steroid cortisol into inactive cortisone (Glover, Bergman, Sarkar, & 
O’Connor, 2009; Harris & Seckl, 2011).  High levels of 11β-HSD2 are expressed in the placenta, 
but these levels are shown to decrease throughout pregnancy, which would explain the increased 
levels of cortisol that reach the developing fetus later in gestation.  It has been hypothesized that 
11β -HSD2 levels lead to increased glucocorticoid signaling within the placenta, and that these 
levels are affected by maternal stress, dietary protein restriction, and possibly oxygen levels 
(Harris & Seckl, 2011). 
The physiological mechanism of cortisol release during pregnancy involves placental 
corticotropin-releasing hormone (pCRH); at around 32 weeks gestation pCRH begins to regulate 
maternal cortisol production rather than maternal CRH (Field & Diego, 2008; Majzoub & 
Karalis, 1999).  The mother’s CRH levels are the highest near delivery, and CRH levels decrease 
to prenatal levels within 24 hours of delivery (Majzoub & Karalis, 1999).   
Due to findings by Glover et al. (2009) that there is a stronger correlation between 
maternal and fetal cortisol among more anxious pregnant women, it is suggested that the 
mother’s emotional state can affect the function of the placenta. Thus, elevated maternal cortisol 
levels may result in elevated fetal cortisol levels by directly crossing the placenta into the fetus.  
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Or, the placenta developed by an anxious mother may have increased pCRH production, 
accelerating the normal physiologic up regulation of the maternal-fetal HPA axes. 
This relationship has been further studied through noting the moderating effect of 
maternal anxiety on the association between maternal plasma and amniotic fluid cortisol 
(O’Donnell et al., 2009).  Depressed women also had higher cortisol levels during their last 
trimester of pregnancy, and this elevated cortisol pattern was reflected in their newborns’ cortisol 
levels (Field & Diego, 2008).  Cortisol release also seems to follow a positive feedback loop 
during pregnancy as opposed to the negative feedback loop that it follows outside of pregnancy 
(Kalra et al., 2007).   
Fetal Programming Hypothesis 
The fetal programming or fetal origins of adult disease hypothesis was created after the 
relationship between prenatal cortisol levels and the development of diseases later in life was 
illuminated.  Since the maternal HPA axis does become more physiologically responsive to 
stress over pregnancy, it seems that this antenatal stress affects fetal development (Barker, Jaffee, 
Uher, & Maughan, 2011; O’Donnell et al., 2009; Osborne & Monk, 2013).  
High levels of cortisol are inherent in cases of maternal psychiatric illnesses such as 
depression and anxiety, and such illnesses activate the maternal HPA axis and then potentially 
program the physiology of the fetal HPA axis (Dunkel Schetter & Tanner, 2012).  Since the fetal 
HPA axis is not yet fully functional, maternal influence on fetal HPA axis development is highly 
influential.  Harris & Seckl (2011) found that mothers who self report anxiety and/or depression 
during pregnancy give birth to offspring with higher basal HPA axis activity at three time 
markers: 6 months, 5 years of age and 10 years of age.  Fetal cortisol, which can be measured in 
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amniotic fluid at delivery, reflects cortisol secreted by the fetus; these levels may be genetically 
determined and also a result of fetal stress due to maternal stress (Glover et al., 2009).  Glover et 
al. (2009) and Field & Diego (2008) also demonstrated that the correlation between maternal and 
fetal (amniotic fluid) cortisol was greater in anxious mothers.  
The fetal programming hypothesis builds off of the primary complication of unnaturally 
high levels of prenatal cortisol, which is low birth weight (LBW).  LBW is characterized as a 
birth weight of ≤ 2500 g (Dunkel Schetter & Tanner, 2012; Field & Diego, 2008; Harris & Seckl, 
2011).  LBW leads to increased vulnerability for disease and neurodevelopmental complications 
later in life.  Some examples of these complications are hypertension, type II diabetes, 
cardiovascular disease, schizophrenia, attention deficit hyperactivity disorder (ADHD), 
antisocial behavior, post-traumatic stress disorder (PTSD), depression, and anxiety disorders 
(Bergman et al., 2010; D’Anna-Hernandez et al., 2011; Glover, 2014; Harris & Seckl, 2011).  
These results suggest that the effects of maternal stress, depression, and anxiety in pregnancy can 
lead to adverse child neurodevelopmental outcomes through fetal programming. 
Cortisol as a Biomarker 
We can measure cortisol levels by extracting cortisol from hair and analyzing it as a 
retrospective biomarker (D’Anna-Hernandez et al., 2011; Hoffman et al., 2016; Kalra et al., 2007; 
Staufenbiel, Penninx, de Rijke, van den Akker, & van Rossum, 2015; Staufenbiel et al., 2013).  
Extracting cortisol from hair collected closest to the scalp can estimate cortisol production 
retrospectively for up to 6 months.  Since hair cortisol levels are averaged over months (or even 
years, recently), hair cortisol profiles differ from salivary or blood cortisol measures, which show 
cortisol levels at exact, single time points.  Therefore, it is important that psychological 
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questionnaires are also used as subjective measures of stress levels to provide further variables 
for analysis.   
Psychological Questionnaires 
The Center for Epidemiologic Studies-Depression Scale (CES-D) is used to screen for 
MDD or clinical depression through a 20-question survey.  Each of these questions has possible 
scores between 0 and 60, and participants rate the frequency of 20 depressive symptoms during 
the past week (Hoffman et al., 2016).  The Spielberg State-Trait Anxiety Inventory, State version 
(STAI) is used to screen for state anxiety through a 20-question survey as well.  Each question 
has possible scores between 20 and 8025, and questions relate to state anxiety symptoms over the 
past month (Hoffman et al., 2016).  While both of these questionnaires rely on self-report, these 
measures are validated in multiple languages and populations, and a higher score indicates a 
higher level of symptomatology (Hoffman et al., 2016). 
Purpose 
As mentioned previously, maternal psychiatric illnesses such as depression and anxiety 
are highly correlated with altered cortisol production and subsequent adverse maternal mental 
health, pregnancy outcomes, fetal development, and neurodevelopmental childhood outcomes.  
Since the risk for these adverse outcomes increases with a mood disorder diagnosis, clinical 
interventions for pregnant women who present with one of these mood disorders are absolutely 
necessary to help improve patient care (Barker et al., 2011; Glover, 2014; O’Donnell et al., 2009).   
Therefore, the purpose of our research was to determine if a history of major depressive 
disorder (MDD) and/or anxiety in the pregnant woman’s mother (MGM) predicted the same 
psychiatric illness in the pregnant mother and if family history of depression and/or anxiety 
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correlates with maternal and fetal HPA axis function as represented by hair cortisol. Since about 
20% of mothers in the general obstetrics population are diagnosed with MDD, 15% are 
diagnosed with an anxiety disorder, and 7.9% are diagnosed with PTSD, it is important to 
examine the effects of these psychiatric illnesses on maternal and fetal HPA axis function 
(Dunkel Schetter & Tanner, 2012; Seng, Low, & Sperlich, 2009).  While the strongest risk factor 
for depression during pregnancy is a history of depression (Rich-Edwards et al., 2006), there is a 
research gap in terms of multigenerational studies that examine the impact of heredity on the 
development of maternal psychiatric illnesses during pregnancy and postpartum periods.  Early 
diagnosis of psychiatric illness, based on family history, may lead to clinical interventions that 
may benefit both maternal and child health.   
Methods 
This study was conducted at Denver Health Medical Center, a safety net hospital located 
in metro Denver, Colorado.  This study is part of a longitudinal study that follows women 
through pregnancy, birth, and the postpartum period and their children from birth up to four 
years of age.  This particular study in the larger longitudinal study seeks to understand how a 
pregnant mother’s mental health influences both pregnancy outcomes and an infant’s brain and 
behavior.  Pregnant patients ≥18 years old without major mental or physical comorbidities were 
enrolled in a prospective longitudinal study at ≤15 weeks gestation during routine prenatal 
clinical visits.  Participants were excluded from the study if they had a history of endocrine 
disorders or chronic steroid use or had an active infection. 
  Family history of psychiatric illness was abstracted from maternal Structured Clinical 
Interview for DSM-IV Disorders (SCID) reports performed by a trained social worker, and 
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maternal diagnoses of MDD and anxiety were compared with the maternal grandmother’s 
psychiatric history.  History and current diagnoses of psychiatric history were collected at both 
obstetric and psychiatric visits (if they occurred during pregnancy), with the pregnant 
participants reporting family history of psychiatric illness.  Through the SCID, maternal 
diagnoses of MDD and anxiety were collected.  
Participants completed the Center for Epidemiological Scales of Depression (CES-D) and 
Spielberg State-Trait Anxiety Inventory (STAI) questionnaires at 5 study time points.  Scores for 
participants who had an MGM with depression and/or anxiety were compared with participants 
who had no family history of psychiatric illness.  Scores were obtained at 16 and 28 weeks and at 
delivery.  Significant scores (i.e., scores that are implicated in diagnosis of anxiety and 
depression) are >16 (CES-D) and >39 (STAI).  
Maternal hair was collected at 16 and 28 weeks and maternal and fetal hair was collected 
at delivery for cortisol analysis.  This provided cortisol data for each trimester of gestation and at 
delivery.  Hair was collected from the posterior vertex of the scalp in women using scissors as 
close to the scalp as possible.  In newborns, hair was collected from the nape of the neck as close 
to the scalp as possible.  Since hair grows approximately 1 cm per month, a length of 
approximately 3 cm of hair was collected for analysis to represent one trimester of hair cortisol 
status. 
To extract cortisol from hair for analysis, hair was washed twice in isopropanol and then 
dried for 4 days (D’Anna-Hernandez et al., 2011; Hoffman et al., 2016).  To prepare the hair for 
centrifugation, it was ground using a Retsch ball mill for ten minutes at 25 Hz until it was ground 
into a fine powder.  This powder was weighed in glass tubes to a weight of 50 mg and then 
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extracted via slow rotation in 1ml of HPLC grade methanol at room temperature for 24 hours. 
After extraction, the consequent methanol and powdered hair solution was transferred to a 2 ml 
micro-centrifuge tube and spun for 120 s in a micro-centrifuge at ~20,000 g.  
Following centrifugation, the resulting supernatant was removed.  The supernatant was 
portioned into a new micro-centrifuge tube and dried at 38 °C for 30 minutes under nitrogen 
(D’Anna-Hernandez et al., 2011). To determine cortisol levels, the supernatant was reconstituted 
with 400 µl of assay buffer, and then cortisol levels were measured with a commercial high 
sensitivity enzyme immunoassay kit from Salimetrics, LLC.  Cortisol levels were recorded for 
data analysis.  Statistical significance for both cortisol and questionnaire values was determined 
using the one-way ANOVA test and the Kruskal-Wallis test, with a p-value < 0.05 considered to 
be significant. 
Results 
Demographics 
The mean birth weight  (± standard deviation), gestational age (± standard deviation), and 
maternal age (± standard deviation) are compiled in Table 1 (Appendix A).  The children of the 
153 pregnant participants had a mean birth weight of 3151.18 ± 606.42 grams, a mean 
gestational age of 38.68 ± 2.77 weeks, and a mean maternal age of 29.38 ± 6.20 years. 
Table 2 (Appendix A) shows the race and ethnicity breakdowns of the participant 
population.  The participant population is predominantly White Hispanic, with 43.79% of 
participants identifying as White Hispanic.   
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Psychiatric Illness Prevalence 
Table 3 (Appendix B) shows the breakdown of psychiatric illnesses that are present in the 
participant population.  Although other psychiatric illnesses (bipolar disorder, schizophrenia, 
substance abuse, etc.) were identified in the participant population, for the purposes of this study 
the focus was on anxiety (including PTSD) and depressive disorders and so only the prevalence 
of those disorders is displayed below.  With a prevalence rate of 33.99% for major depressive 
disorder (MDD) without psychosis and a prevalence rate of 18.3% for post-traumatic stress 
disorder (PTSD), this participant population had higher prevalence rates of these disorders than 
the general obstetrics population.  PTSD is diagnosed as a specific anxiety disorder under the 
DSM-IV, but is a stand-alone psychiatric illness according to the recently released DSM-V.  For 
this study, PTSD is treated as an anxiety disorder with this recent change in mind. 
Table 4 (Appendix B) shows the percentage of pregnant participants with a family history 
of psychiatric illness when broken down into psychiatric illness groups.  It is important to note 
that 24.84% of pregnant participants had a family member who was diagnosed with multiple 
psychiatric illnesses, and no MGM history of PTSD was recorded in this population. 
Table 5 (Appendix B) shows the percentage of pregnant participants who were diagnosed 
with the same psychiatric illness as at least one of their family members.  69.7% of participants 
who had a family member with MDD were also diagnosed with MDD, and 7.69% of participants 
who had a family member with an anxiety disorder were also diagnosed with an anxiety disorder. 
The one-way ANOVA statistical test and the Kruskal-Wallis statistical test were used to 
determine statistical significance across results.  The Kruskal-Wallis statistical test is used for 
non-parametric populations and is best described as a one-way ANOVA test that is utilized 
between groups of independent variables.  A p-value < 0.05 was considered significant. 
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Figure 1 (Appendix C) depicts the Spielberg State-Trait Anxiety Inventory (STAI) scores 
for pregnant participants as separated into those participants with a family history of anxiety 
(+FH) and those without a family history of anxiety (no FHx) as recorded at each trimester.  A p-
value of 0.005 shows statistical significance between the group of participants with a family 
history of anxiety and the group of participants without a family history of anxiety between all 
trimesters. 
Figure 2 (Appendix C) depicts the Center for Epidemiological Scales of Depression 
(CES-D) scores for pregnant participants as separated into those participants with a family 
history of major depressive disorder (+FH) and those without a family history of major 
depressive disorder (no FHx) as recorded at each trimester.  A p-value of 0.02 shows statistical 
significance between the group of participants with a family history of major depressive disorder 
and the group of participants without a family history of major depressive disorder over all 
trimesters.  
Table 6 (Appendix C) shows the mean levels of maternal cortisol at each trimester as 
well as the mean level of fetal (neonatal) cortisol at delivery as extracted from hair.  The standard 
deviations for each measure are also listed.   
Figure 3 (Appendix D) depicts hair cortisol levels (pg/mg) separated by each trimester of 
pregnancy and grouped by race and ethnicity categories.  A p-value of less than 0.0001 between 
the first trimester hair cortisol values and a p-value of 0.0004 between the second trimester hair 
cortisol values shows a statistically significant difference in hair cortisol levels between race and 
ethnicity categories.  A p-value of 0.0796 between the third trimester hair cortisol values shows 
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no statistical difference in the hair cortisol levels between race and ethnicity categories during 
the third trimester of pregnancy. 
Figure 4 (Appendix D) shows the statistically significant increase (p = 0.0063) in hair 
cortisol levels (pg/mg) within all subjects throughout pregnancy.   
 Figure 5 (Appendix D) depicts hair cortisol levels (pg/mg) for each trimester as separated 
into family history of psychiatric illness groups.  A p-value of 0.6827 for the first trimester hair 
cortisol levels showed no statistical significance between groups.  P-values of 0.9327 and 0.3442 
for the second and third trimester hair cortisol levels, respectively, also showed no statistical 
significance between groups.  Additionally, there is no increase in cortisol levels throughout 
pregnancy in the separate family history of psychiatric illness or no family history of psychiatric 
illness groups, which is contrary to what is expected through the literature. 
Figure 6 (Appendix E) shows the percent change in hair cortisol levels (pg/mg) between 
the first and second, the first and third, and second and third trimesters for each family history of 
psychiatric illness group.  A p-value of 0.02 between groups dictates statistical significance 
between hair cortisol levels for each trimester amongst family history of psychiatric illness 
groups. 
Discussion 
The purpose of this study was to determine if a history of major depressive disorder 
(MDD) and/or anxiety in the pregnant woman’s mother (MGM) predicts the same psychiatric 
illness in the pregnant mother and if family history of depression and/or anxiety correlates with 
maternal HPA axis function as represented by hair cortisol.  Our data suggest that family history 
of psychiatric illness in the MGM influences the appearance of symptoms of the same 
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psychiatric illness in the pregnant mother as seen through CES-D and STAI scores and 
psychiatric diagnosis.  We did not find significant influences of family history in the MGM on 
maternal HPA axis function as represented by hair cortisol. 
To begin, it is important to note that there are higher rates of diagnosed MDD and anxiety 
(including PTSD) in this subject population as compared to the general obstetrics population 
(Table 3, Appendix B).  This population, however, is representative of the patient population 
seen at Denver Health Medical Center and is consistent with findings in other vulnerable 
populations.   37% percent of pregnant participants in this study had a family member whose 
diagnosis was comorbid with at least one other psychiatric illness.   
 Figures 1 and 2 (Appendix C) show that participants with psychiatric illness in the MGM 
have higher CES-D and STAI scores at all study time points, regardless of the pregnant 
participant’s diagnosis of anxiety or MDD.  This was a statistically significant result, and is very 
important, because it shows that even if the pregnant participant does not have a psychiatric 
illness diagnosis, her scores on subjective measure questionnaires are significantly higher during 
pregnancy, and higher scores mean increased likelihood of diagnosis of MDD (CES-D) and 
anxiety (STAI).  This result could be due to a hereditary influence on the development of 
depression and anxiety symptomatology and ultimately on development of these psychiatric 
illnesses.  Although a particular gene has not yet been identified that could prove this hereditary 
relationship, these results suggest that there could be a mechanism that is involved in a 
predisposition to development of psychiatric illnesses if one has a family history of psychiatric 
illness. 
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As shown by Figure 3 (Appendix D), there are statistically significant differences in hair 
cortisol levels between participants in race and ethnicity categories during the first and second 
trimesters of pregnancy, but not during the third trimester of pregnancy.  It could be important to 
continue to examine differences in antenatal care based on these results, as participants in the 
Black Non-Hispanic group had consistently higher hair cortisol levels throughout the first and 
second trimesters as compared to participants in the other race and ethnicity categories, and this 
result is seen often.  These results suggest that there may be different baseline cortisol reactivity 
levels between race and ethnicity groups and/or that there is an effect of race and ethnicity on the 
HPA axis during pregnancy (and possibly outside of pregnancy). 
Figure 4 (Appendix D) shows that the means levels of hair cortisol increased during 
pregnancy across all 153 participants in the study, which is consistent with the expectation of 
hypercortisolemia throughout pregnancy.  However, when participants are separated into groups 
based on their family history of psychiatric illness diagnosis, this significance is no longer 
present, as discussed below and shown by Figure 5. 
Figure 5 (Appendix D) shows that participants with a family history of anxiety and MDD 
do not show a significantly different increase or decrease in cortisol over pregnancy when 
compared with participants that have no family history of psychiatric illness.  This result 
reinforces the conclusion reached through the literature review that there is not yet a consensus 
on whether MDD leads to an increase or decrease in cortisol levels.  We expected an increase in 
cortisol levels in those participants with a family history of anxiety, but our statistical results do 
not support this increase.  This unexpected result could be due to sample size, since there were 
13 participants with a family history in the MGM of anxiety (including PTSD), but only 7 of 
these participants had complete hair cortisol data for analysis.  Further, we would expect the 
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group of participants with no family history of psychiatric illness to show a steady increase in 
hair cortisol levels over pregnancy, however, that is not seen in our results, most likely due to 
data outliers, sample size and errors with cortisol extraction from hair samples. 
Although utilizing hair cortisol as a retrospective biomarker is a relatively new method, 
studies have found that both salivary and hair cortisol are reliable measures of cortisol levels.  
The lack of expected hypercortisolemia in the group of participants with no history of psychiatric 
illness resulted in a non-significant statistical result in hair cortisol levels over pregnancy 
between participants with a family history of psychiatric illness and those participants without a 
family history of psychiatric illness.   
An important note regarding this result is that the use of hair cortisol to measure HPA 
axis activity measures a different aspect of the HPA axis than the use of single time point cortisol 
measures using saliva or blood.  Salivary cortisol provides a snapshot of a participants’ same-day 
cortisol status while hair cortisol provides a long-term profile of a participants’ (chronic) cortisol 
levels (D’Anna-Hernandez et al., 2011).  Hair cortisol is averaged over months and measures 
long-term cortisol levels and stress reactivity, while saliva and blood measure short-term cortisol 
levels and activity and is particularly valuable with providing information about cortisol 
dynamics and stress reactivity (Staufenbiel et al., 2013).  To study the role of cortisol in 
psychiatric illnesses, it may be beneficial to look at both measures: salivary and blood cortisol 
levels to determine baseline cortisol reactivity and hair cortisol levels to examine long-term 
chronic cortisol status. 
There was a non-significant statistical result in hair cortisol levels over pregnancy 
between participants with a family history of psychiatric illness and those participants without a 
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family history of psychiatric illness.  Even when not significantly represented by cortisol, there 
seems to be a cross-generational prediction of MDD, as 69.7% of mothers with a family history 
of MDD were also diagnosed with MDD.  There does not seem to be as much of a cross-
generational diagnostic prediction of anxiety, as only 7.69% of mothers with a family history of 
anxiety were also diagnosed with anxiety, but this is also inherently due to the small sample size 
of participants who were diagnosed with anxiety. 
Figure 6 (Appendix E) shows the changes in hair cortisol levels throughout pregnancy 
between trimesters and across groups of participants with no family history of psychiatric illness 
and those with family history of anxiety and MDD.  The bars for the family history of anxiety 
and MDD groups show the blunted cortisol change between trimesters, and the bars for the no 
family history of psychiatric illness group show a 200% increase in hair cortisol levels between 
the first and second trimesters and a 200% decrease in hair cortisol levels between the second 
and third trimesters.  This result is largely due to an outlier in the no family history of psychiatric 
illness group.  When this outlier’s data was removed from the statistical test, a statistically 
significant result was still observed over all trimesters between groups since the hair cortisol data 
is natural log transformed to create a more normal distribution, so we retained her data values.   
Overall, these data suggest a multigenerational effect of mental illness on mood 
symptomatology as qualified through similarities in psychiatric diagnosis between pregnant 
women and their mothers, and the influences of family history on CES-D and STAI scores.  
These data also suggest that patients diagnosed with anxiety or MDD may have a different 
regulatory mechanism for cortisol during pregnancy, which supports the need for further 
research into the mechanism of cortisol release during pregnancy. 
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It is important to note that the stigma surrounding psychiatric illnesses has decreased in 
recent years, but that this stigma used to be enormously prevalent (and still is quite prevalent).  It 
is possible that some maternal grandmothers were not diagnosed with a psychiatric illness due to 
this stigma, and therefore that these psychiatric illness statistics were not reflected in the family 
history of psychiatric illness data collection. 
Finally, the implications of this study suggest that we should consider assessment of both 
maternal mental health and psychiatric family history during antenatal care.  Family history of 
psychiatric illness could offer an avenue into early recognition and treatment of psychiatric 
illnesses during antenatal care and, since approximately 60% of female patients only see a doctor 
regularly during pregnancy (M. V Smith et al., 2004), utilizing antenatal care as a way to 
intercede with mental health could be a useful and successful patient care approach. 
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Appendix A 
Demographic Mothers (N=153) 
Birth Weight (g) ± std 3151.18 ± 606.42 
Gestational Age (wks) ± std 38.68 ± 2.77 
Maternal Age (yrs) ± std 29.38 ± 6.20 
Table 1. Maternal demographics. 	
Race & Ethnicity Mothers (N=153) 
White Non-Hispanic 50 (32.68%) 
White Hispanic 67 (43.79%) 
African American Non-
Hispanic 
14 (9.15%) 
African American 
Hispanic 
0 (0%) 
AIAN Non-Hispanic 4 (2.61%) 
AIAN Hispanic 7 (4.58%) 
Mixed Non-Hispanic 6 (3.92%) 
Mixed Hispanic 5 (3.27%) 
Table 1. Maternal race and ethnicity breakdown. 										
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Appendix B 
Psychiatric Illness Mothers with 
Psychiatric Illness 
Diagnosis (N=153) 
Anxiety disorder (including 
PTSD) 
37 (24.18%) 
MDD 52 (33.99%) 
Minor DD 11 (7.19%) 
No diagnosis 24 (15.69%) 
None listed 25 (9.80%) 
Table 3. Maternal psychiatric illness diagnoses according to SCID reports (MDD = major depressive disorder, 
DD = depressive disorder, PTSD = post-traumatic stress disorder). 	
Psychiatric Illness Mothers with a MGM 
History of Psychiatric 
Illness (N=153) 
Alcohol abuse 43 (28.10%) 
Anxiety disorder 13 (8.50%) 
MDD 33 (21.57%) 
Substance abuse 15 (9.80%) 
2 or more illnesses 38 (24.84%) 
None listed 83 (54.24%) 
Table 4. Percentage of pregnant participants with a family history of psychiatric illness diagnoses in the 
maternal grandmother as obtained through SCID reports (MDD = major depressive disorder). 					
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Psychiatric Illness Mothers with Same 
Psychiatric Diagnosis as 
MGM 
MDD 23/33 (69.7%) 
Anxiety disorder 1/13 (7.69%) 
Table 5. Percentage of pregnant participants who were diagnosed with the same psychiatric illness as their 
mother. 
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Appendix C 
Time Period Cortisol Means 
(pg/mg) ± std 
1st trimester cortisol 9.3 ± 10.53 
2nd trimester cortisol 10.8 ± 13.27 
3rd trimester cortisol 15.6 ± 18.84 
Fetal cortisol at delivery 291.2 ± 637.65 
Table 6. Mean maternal levels of cortisol at each trimester and mean level of fetal cortisol at delivery. 
	
Figure 1.  Maternal STAI scores at each trimester (n=102), separated by those participants with a family 
history of anxiety (+FH) and participants without a family history of anxiety (no FHx).  A p-value of 0.005 
showed significant results between +FH and no FHx subject groups under the Kruskal-Wallis test. 		
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Figure 2.  Maternal CES-D scores at each trimester (n=102), separated by those participants with a family 
history of major depressive disorder (+FH) and participants without a family history of major depressive 
disorder (no FHx).  A p-value of 0.02 showed significant results between +FH and no FHx subject groups 
under the Kruskal-Wallis test. 																		
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Appendix D 
 
 
Figure 3.  Maternal hair cortisol levels (pg/mg) grouped by race and ethnicity and separated by trimester of 
pregnancy (n=87).  A one-way ANOVA test shows statistical significance between race and ethnicity groups 
during the first (p < 0.0001) and second (p = 0.0004) trimesters of pregnancy, while a one-way ANOVA test 
shows no statistical significance between race and ethnicity groups during the third trimester of pregnancy (p 
= 0.0796). 
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Figure 4.   Hair cortisol levels (pg/mg) across all subjects in the study (n=87) throughout pregnancy.  A one-
way ANOVA statistical test shows significant differences between trimesters, as denoted by the p-value of 
0.0063. 											
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Figure 5.  Maternal hair cortisol levels by trimester, separated by participants with no family history of 
psychiatric illness (no FHx), participants with family history of anxiety and PTSD (anxiety/PTSD), and 
participants with family history of major depressive disorder (MDD) (n=75).  A one-way ANOVA test showed 
no statistical significance between subject groups. 									
MULTIGENERATIONAL DEPRESSION AND ANXIETY & MATERNAL MEASURES 
OF STRESS		 	 		 37 
Appendix E 
	
Figure 6.  Percent change in maternal hair cortisol levels between trimesters, separated by participants with 
no family history of psychiatric illness (no FHx), participants with family history of anxiety (anxiety), and 
participants with family history of major depressive disorder (MDD) (n=75).  A p-value of 0.02 showed 
significant results between +FH and no FHx subject groups under the Kruskal-Wallis test. 
 
